IGC Pharma, Inc. IGC
0.28
0.00
0.00%
as of 25 Sep
- Market cap
- $29.1M
- P/E
- 0.0×
Follow IGC
Growth Flags
show if company had growth for consecutive years
| Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
17.55 | 21.00 | 19.62 | 119.63 | 83.65 | 4.75 | 13.97 | 6.88 | 20.78 | 1.34 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(30.55) | (5.43) | (2.54) | (6.36) | (6.95) | (2.23) | (21.47) | (7.81) | (8.67) | (54.03) |
P/B ratio |
3.52 | 3.86 | 1.20 | 1.99 | 2.29 | 0.73 | 2.13 | 1.87 | 1.64 | 0.61 |
Price to Tangible BV |
4.98 | 4.95 | 1.30 | 2.07 | 2.32 | 0.74 | 2.14 | 1.90 | 1.69 | 0.67 |
EV/Sales |
17.44 | 20.31 | 16.25 | 93.65 | 68.00 | 1.85 | 8.99 | 6.32 | 21.42 | 1.26 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(4.62) | (2.77) | (1.18) | (2.65) | (3.20) | (0.49) | (8.34) | (4.78) | (6.63) | (52.36) |
EV/FCF |
(4.23) | (2.60) | (1.18) | (2.48) | (2.76) | (0.32) | (8.18) | (4.08) | (5.79) | (33.41) |
Quick Ratio |
0.19 | 0.53 | 1.82 | 4.34 | 6.25 | 6.41 | 29.26 | 1.01 | 2.46 | 0.77 |
Current Ratio |
1.28 | 1.58 | 3.41 | 6.19 | 9.93 | 9.12 | 30.44 | 1.37 | 2.78 | 1.20 |
Net Debt/EBITDA |
0.04 | 0.12 | 0.28 | 0.70 | 1.70 | 1.76 | 5.58 | (0.24) | (0.14) | 0.22 |
Debt/Assets |
1.53% | 1.38% | 1.61% | 0.55% | 1.62% | 1.85% | 0.15% | 20.52% | 23.43% | 5.40% |
Debt/Equity |
0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.00 | 0.28 | 0.36 | 0.07 |
Asset Turnover |
0.14 | 0.10 | 0.04 | 0.01 | 0.03 | 0.13 | 0.23 | 0.20 | 0.04 | 0.32 |
Operating CF/Net income |
0.67 | 0.40 | 0.61 | 0.50 | 1.23 | 1.19 | 0.81 | 1.08 | 0.75 | 0.06 |
Capex/Depreciation |
(0.72) | (0.74) | (0.12) | (1.14) | (3.23) | (31.01) | (1.02) | (10.58) | (0.37) | (0.17) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (104.33%) | (116.95%) | (59.30%) | (52.97%) | (29.70%) | (24.34%) | (19.68%) | (23.17%) | (17.53%) | (19.57%) | |
| (76.37%) | (96.01%) | (52.29%) | (47.90%) | (27.17%) | (23.06%) | (18.08%) | (16.14%) | (12.39%) | (14.33%) | |
ROIC |
(76.81%) | (97.82%) | (61.09%) | (71.01%) | (29.07%) | (29.12%) | (36.22%) | (13.18%) | (16.95%) | (13.48%) |
Return on Tangible Assets |
(184.53%) | (256.92%) | (90.02%) | (67.98%) | (27.54%) | (28.58%) | (12.91%) | (25.17%) | (57.53%) | (36.39%) |
Average Days of Receivables |
9.76 | 10.58 | 42.87 | 114.92 | 71.13 | 11.92 | 5.99 | 92.87 | 473.48 | 55.19 |
Research and Development Expense of Revenue |
287.57% | 280.52% | 379.91% | 586.90% | 103.45% | 24.83% | 24.55% | 6.25% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
346.97% | 502.45% | 938.75% | 3,348.11% | 880.62% | 146.56% | 68.78% | 79.07% | 391.40% | 42.45% |
Intangible Assets out of Total Assets |
0.21 | 0.16 | 0.07 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.07 |
Share Based Compensation of Revenue |
129.03% | 131.82% | 312.07% | 553.40% | 73.27% | 18.91% | 11.92% | 26.27% | 43.18% | 0.00% |
Graham Net Nets |
0.02 | 0.04 | 0.23 | 0.26 | 0.27 | 0.79 | 0.36 | 0.03 | (0.03) | (0.13) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(30.36%) | (45.83%) | (64.71%) | (32.63%) | (12.29%) | (36.73%) | (6.93%) | (12.96%) | (14.89%) | (32.69%) |
Free Cash Flow Yield |
(23.48%) | (37.15%) | (70.28%) | (31.52%) | (29.44%) | (121.81%) | (7.86%) | (22.55%) | (17.82%) | (2.83%) |
Revenue per Share |
0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.10 | 0.14 | 0.08 | 0.02 | 0.39 |
Operating CF per Share |
(0.06) | (0.09) | (0.13) | (0.15) | (0.26) | (0.22) | (0.09) | (0.07) | (0.05) | (0.01) |
Capex per Share |
(0.01) | (0.01) | 0.00 | (0.01) | (0.04) | (0.11) | 0.00 | (0.01) | (0.01) | (0.01) |
Free Cash Flow per Share |
(0.07) | (0.10) | (0.14) | (0.16) | (0.29) | (0.33) | (0.10) | (0.08) | (0.06) | (0.02) |
Cash per Share |
0.01 | 0.02 | 0.06 | 0.21 | 0.35 | 0.31 | 0.72 | 0.06 | 0.09 | 0.09 |
Shareholders Equity per Share |
0.08 | 0.12 | 0.28 | 0.48 | 0.78 | 0.67 | 0.95 | 0.29 | 0.29 | 0.85 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.08 | 0.12 | 0.28 | 0.48 | 0.78 | 0.67 | 0.95 | 0.29 | 0.29 | 0.85 |
Free Cash Flow |
(5.24) | (5.67) | (7.13) | (8.20) | (12.34) | (13.14) | (3.39) | (2.13) | (1.54) | (0.28) |
Working Capital |
0.64 | 1.37 | 4.57 | 12.67 | 21.15 | 15.81 | 25.85 | 0.86 | 2.29 | 0.64 |
Capital Expenditures |
(0.44) | (0.47) | (0.08) | (0.74) | (1.54) | (4.47) | (0.06) | (0.20) | (0.15) | (0.12) |
Net Current Asset Value |
0.48 | 1.12 | 4.20 | 12.17 | 20.45 | 15.31 | 25.83 | 0.42 | (0.35) | (1.07) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.35 | 0.35 | 0.09 | 1.87 | 1.72 | 1.10 | 0.01 | 0.09 | 0.25 | 0.02 |
Net Profit Margin |
(560.27%) | (966.54%) | (1,263.01%) | (3,782.37%) | (981.18%) | (179.64%) | (80.08%) | (81.44%) | (321.73%) | (44.11%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.19 | 0.17 | 0.08 | 0.07 | 0.04 | 0.01 | 0.01 | 0.00 | 0.42 | 0.10 |
Cash ROIC |
(116.68%) | (102.75%) | (82.32%) | (48.93%) | (45.07%) | (46.83%) | (15.56%) | (67.52%) | (18.89%) | (43.94%) |
Accounts Receivable Turnover |
34.82 | 18.42 | 7.85 | 2.65 | 5.83 | 37.53 | 15.94 | 3.35 | 0.68 | 6.51 |
Accounts Payable Turnover |
0.79 | 0.94 | 0.62 | 0.28 | 1.27 | 7.32 | 17.28 | 6.26 | 0.97 | 21.87 |
Inventory Turnover |
0.45 | 0.29 | 0.15 | 0.05 | 0.16 | 1.76 | 13.58 | 6.51 | 0.00 | 12.67 |
Average Days of Payables |
494.32 | 461.02 | 412.47 | 1,763.87 | 221.32 | 70.29 | 23.36 | 44.61 | 419.84 | 21.85 |
Days of Inventory on Hand |
761.35 | 918.46 | 2,063.15 | 6,379.41 | 2,547.10 | 391.57 | 18.16 | 84.03 | 0.00 | 10.71 |
Average Receivables |
0.04 | 0.07 | 0.12 | 0.15 | 0.15 | 0.11 | 0.32 | 0.66 | 0.86 | 0.98 |
Average Payables |
0.83 | 0.65 | 0.76 | 0.73 | 0.62 | 0.54 | 0.29 | 0.34 | 0.37 | 0.25 |
Average Inventory |
1.45 | 2.10 | 3.10 | 4.51 | 4.86 | 2.25 | 0.37 | 0.32 | — | 0.44 |
Average Assets |
9.32 | 13.54 | 22.01 | 31.35 | 32.43 | 31.72 | 22.66 | 11.07 | 15.07 | 19.60 |
Average Common Equity |
6.83 | 11.12 | 19.40 | 28.35 | 29.67 | 30.05 | 20.82 | 7.71 | 10.65 | 14.35 |
Columns are period end dates